Cita APA

Ding, Z., Alshreef, A., Favaro, E., Hoehn, D., Sureda, A., Danilov, A. V., . . . Wang, A. (2025). Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma.

Citación estilo Chicago

Ding, Zhijie, et al. Indirect Comparison of Epcoritamab Vs Chemoimmunotherapy, Mosunetuzumab, or Odronextamab in Follicular Lymphoma. 2025.

Cita MLA

Ding, Zhijie, et al. Indirect Comparison of Epcoritamab Vs Chemoimmunotherapy, Mosunetuzumab, or Odronextamab in Follicular Lymphoma. 2025.